Posted inBiotechnology
Mushrooms could soon help create your next handbag
A handbag grown from fungus could offer a new route beyond both animal leather and petroleum-based vegan alternatives. Researchers in…
Posted inBiotechnology
JMIR Publications Partners With UMass Chan Medical School on Unlimited Open-Access Publishing
UMass Chan and JMIR Publications Launch Open Access Partnership to Remove Publishing Fees for Digital Health Researchers A new publishing…
Posted inBiotechnology
Oviduct Epithelial Folds Aid Oocyte Transport but Aren’t Essential
After ovulation, an egg begins a carefully timed journey through the oviduct, also known as the Fallopian tube, toward the…
Posted inGenetics
DNA Script Wins ARPA-H Award to Advance DNA Manufacturing
DNA, illustration. [Polesnoy/Getty Images] DNA Script, in collaboration with GE HealthCare, has been awarded up to $26 million in funding…
Posted inBiotechnology
Nationwide study links proximity to dry cleaners with Parkinson’s disease risk
Parkinson’s disease has long been studied through the lenses of aging, genetics and the nervous system’s response to environmental stress.…
Posted inBiotechnology
Early Parkinson’s disease: α-Synuclein disrupts co-translational protein transport into the endoplasmic reticulum
Parkinson’s disease may begin damaging cells long before tremors, stiffness, and slowed movement become visible. A new study published in…
Posted inBiotechnology
Double shot of Vistagen’s anxiety nasal spray can’t beat placebo in ph. 2 trial
Following a string of clinical setbacks, Vistagen’s nasal spray for social anxiety has now failed to top placebo even when…
Posted inBiotechnology
Study profiles GCase activity and α-synuclein proteoforms in Parkinson’s disease brains
A new study is bringing molecular precision to one of Parkinson’s disease’s most important biological puzzles: why changes in the…
Posted inBiotechnology
Inflammatory Bowel Disease Linked to Higher Risk of Psychiatric Disorders
Inflammatory bowel disease (IBD) may begin affecting the mind years before it is formally diagnosed, according to a nationwide Swedish…
Posted inBiotechnology
Tarsus pays $450M for Alkeus and its phase 3-stage retinal disease drug
Tarsus Pharmaceuticals is fronting $450 million to acquire Alkeus Pharmaceuticals for its phase 3-stage retinal disease therapy that's being touted…